MedTrace Logo

Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain

NCT02104050 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 202

Last updated 2017-10-06

No results posted yet for this study

Summary

The objectives of this trial are to investigate the efficacy and safety of six weeks of treatment with OLT1177 Gel in subjects with moderate to severe pain associated with osteoarthritis of the knee following cessation of pain therapy.

Conditions

Interventions

DRUG

Placebo Gel

6 mL of Placebo Gel administered TID for 6 weeks

DRUG

OLT1177 Gel

6 mL of OLT1177 Gel (5%) administered TID for 6 weeks

Sponsors & Collaborators

  • Olatec Therapeutics LLC

    lead INDUSTRY

Principal Investigators

  • William Cunningham, MD, FAAD · Cu-Tech, LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02104050 on ClinicalTrials.gov